Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, September 1 2015 6:19am ET - U.S. Markets open in 3 hours and 11 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Major News
Latest News
Monday, Aug 31, 2015
·PRESS DIGEST- British Business - Sept 1
Reuters - Mon 8:28 pm ET
·How Google looks to change the management of diabetes
at bizjournals.com - Mon 7:55 pm ET
·A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear
at Motley Fool - Mon 5:02 pm ET
·The 4 Stocks That Hobbled the Dow on Monday
- Mon 4:01 pm ET
·Bayer's Latest Stage 2 Trial Could Be A Boon For Shares
- Mon 3:14 pm ET
·5 Things MannKind Corporation's Management Team Wants You To Know
at Motley Fool - Mon 1:46 pm ET
·Bristol-Myers buys rights to fibrosis drug
AP - Mon 9:22 am ET
·Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
GlobeNewswire - Mon 9:20 am ET
·Bristol-Myers Granted Right to Buy Promedior
at The Wall Street Journal Online - Mon 9:02 am ET
·Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
PR Newswire - Mon 9:01 am ET
·Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases
Business Wire - Mon 8:30 am ET
·3 Major Hurdles the Marijuana Industry May Not Overcome
at Motley Fool - Mon 8:07 am ET
·ALK obtains European approval for its house dust mite sublingual allergy immunotherapy tablet against allergic rhinitis and allergic asthma
GlobeNewswire - Mon 7:41 am ET
·Power, Rail, Pharma Lead Northeast in $100 Billion of Planned Projects, an Industrial Info News Alert
Marketwire - Mon 6:30 am ET
·Bayer heart failure drug cuts deaths in mid-stage trial
Reuters - Mon 5:12 am ET
·CELG, PFE, REGN, RCPT Jim Cramer's Views
at TheStreet.com - Mon 1:00 am ET
Sunday, Aug 30, 2015
·Novogen Announces The Outcome Of A Comprehensive Science Review
PR Newswire - Sun 7:00 pm ET
·Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute Announce Worldwide Collaboration to Discover Novel Immuno-Oncology Antibodies
Business Wire - Sun 7:00 pm ET
Saturday, Aug 29, 2015
·Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
at Motley Fool - Sat Aug 29
·Janssen Pharmaceuticals Accused of Hiding Risperdal's Breast Effects In Boys
at Forbes.com - Sat Aug 29
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?